Evaluating the Safety and Efficacy of Decitabine in the Treatment of XMEN Patients

NCT07555405 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

MAGT1 Deficiency

Interventions

DRUG: Decitabine

Sponsor

Children's Hospital of Fudan University

Collaborators

[object Object]